# Gastrin‐Releasing Peptide Facilitates Cholinergically Mediated Contractions of the Mouse Gastric Fundus

**Authors:** Diego Currò, Raj Makwana, Gareth J. Sanger

PMC · DOI: 10.1002/prp2.70151 · Pharmacology Research & Perspectives · 2025-07-18

## TL;DR

Gastrin-releasing peptide enhances muscle contractions in the mouse stomach by boosting cholinergic nerve activity.

## Contribution

This study reveals a new role for gastrin-releasing peptide in modulating cholinergic contractions in the mouse gastric fundus.

## Key findings

- GRP, NMB, and BB induce concentration-dependent muscle contractions in mouse gastric fundus.
- GRP potentiates electrically evoked cholinergic contractions via BB2 receptor activation.
- GRP's effect is blocked by the BB2 receptor antagonist BW-10 but not by the BB1 receptor antagonist PD168368.

## Abstract

Gastrin‐releasing peptide (GRP) and neuromedin B (NMB) are found in the stomach's myenteric plexus and muscular layers. When exogenously administered, they contract stomach muscle in several species, but their ability to modulate enteric nerve functions has rarely been studied. We investigated the effects of GRP on cholinergic‐mediated contractions of the stomach, after first characterizing the contractile effects of GRP, NMB, and bombesin (BB). Circular muscle rings, cut from the mouse gastric fundus, were studied using tissue bath techniques. Contractions evoked by electrical field stimulation (EFS; 5 Hz) were examined under non‐adrenergic, non‐nitrergic conditions. Contractions were expressed as % of the maximum contraction induced by carbachol (100 μM). GRP (0.0001–1 μM), NMB (0.0001–3 μM), and BB (0.0001–1 μM) induced concentration‐dependent tonic muscle contractions. The pD2 and E

max
 were, respectively, GRP: 7.2 ± 0.1, 54.6% ± 3.6% (n = 14); BB: 7.4 ± 0.2, 47.2% ± 3.9% (n = 9); and NMB: 6.3 ± 0.1, 38.1% ± 5.6% (n = 10). GRP‐ and NMB‐induced contractions were inhibited by the BB2 receptor antagonist BW‐10, not by the BB1 receptor antagonist PD168368. EFS‐evoked contractions were blocked by atropine (1 μM) or tetrodotoxin (1 μM), and concentration‐dependently potentiated by GRP (0.0001–1 μM), with pD2 and E

max
 values 7.8 ± 0.1 and 81.2% ± 14.0%, respectively (n = 17). This activity was inhibited by BW‐10, not PD168368. BW‐10 alone also reduced EFS‐evoked contraction amplitudes. GRP and BW‐10 did not affect contractions induced by bethanechol (1–300 μM). In conclusion, in mouse gastric fundus, GRP causes muscle contraction and also facilitates electrically evoked cholinergic activity (facilitating ACh release), both actions most likely involving BB2 receptor activation. Further experiments must ascertain the physiological significance of these actions, alone and together.

Gastrin‐releasing peptide concentration‐dependently potentiates the cholinergic contractions of mouse gastric fundus circular muscle evoked by electric field stimulation.

## Linked entities

- **Proteins:** grp (gastrin releasing peptide)
- **Chemicals:** carbachol (PubChem CID 5831), BW-10 (PubChem CID 164442), PD168368 (PubChem CID 9937534)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Grp (gastrin releasing peptide) [NCBI Gene 225642] {aka BLP}, Nmb (neuromedin B) [NCBI Gene 68039] {aka 3110023K12Rik}
- **Chemicals:** ACh (MESH:D000109), PD168368 (MESH:C419604), tetrodotoxin (MESH:D013779), bethanechol (MESH:D018723), carbachol (MESH:D002217), BW-10 (MESH:C077908), atropine (MESH:D001285)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12273184/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12273184/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12273184/full.md

---
Source: https://tomesphere.com/paper/PMC12273184